NeuroOne Added to Russell Microcap Index, Expanding Investor Visibility

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on neurological disorders, has been added to the Russell Microcap Index as part of the 2026 Russell indexes reconstitution, effective when the U.S. market opens on June 29. The addition is expected to enhance the company's visibility among investment managers and institutional investors who use Russell indexes as benchmarks for active investment strategies and index funds.

The Russell Microcap Index consists of the smallest 1,000 securities in the Russell 2000 Index, plus the next 1,000 smallest eligible securities by market capitalization. Membership in the Russell 3000 Index, which remains in place for six months, also means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index, as well as appropriate growth and value style indexes. According to FTSE Russell, as of the end of June 2025, approximately $12.2 trillion in assets were benchmarked against the Russell US indexes.

NeuroOne's inclusion follows the semi-annual June reconstitution, which ranks the 4,000 largest U.S. stocks by total market capitalization as of April 30. FTSE Russell determines membership primarily through objective market-capitalization rankings and style attributes. For more details on the reconstitution, visit the FTSE Russell website.

NeuroOne markets a minimally invasive and high-definition electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System for the brain, and OneRF Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering both diagnostic and therapeutic functions. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs.

The addition to the Russell Microcap Index could provide NeuroOne with increased exposure to a broader investor base, as many institutional investors and index funds track these indexes. This move underscores the company's growth trajectory and its potential to attract more attention from the investment community. For more information about NeuroOne, visit the company's website at nmtc1.com.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is NeuroOne Added to Russell Microcap Index, Expanding Investor Visibility.